ExploreWatchlistsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Net income margin (%)

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Market cap
$40.5B
P/E ratio
131.1x
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 20258.4-168.28%
Dec 31, 2024-12.4-48.62%
Dec 31, 2023-24.1-77.92%
Dec 31, 2022-109+7.94%
Dec 31, 2021-101-42.00%
Dec 31, 2020-174.1-56.81%
Dec 31, 2019-403.2-60.33%
Dec 31, 2018-1,016.6+2237.11%
Dec 31, 2010-43.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat